Virtu Financial’s VolitionRx Ltd VNRX Stock Holding History

Virtu Financial’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,429	Closed	-$28K	–	2356
2025 Q4	$28K	Buy	5,429 +3,392	+167%	+$25.8K	﹤0.01%	1374
2025 Q3	$28K	Buy	+2,037	New	+$27.1K	﹤0.01%	1240
2025 Q1	–	Sell	-612	Closed	-$7K	–	2084
2024 Q4	$7K	Buy	+612	New	+$8.21K	﹤0.01%	1419
2024 Q1	–	Sell	-1,335	Closed	-$19K	–	2145
2023 Q4	$19K	Buy	+1,335	New	+$19.6K	﹤0.01%	1330
2022 Q4	–	Sell	-1,878	Closed	-$51K	–	2174
2022 Q3	$51K	Buy	+1,878	New	+$71K	﹤0.01%	1200
2021 Q1	–	Sell	-2,219	Closed	-$173K	–	2054
2020 Q4	$173K	Buy	+2,219	New	+$153K	0.02%	902
2019 Q4	–	Sell	-1,006	Closed	-$113K	–	1891
2019 Q3	$113K	Buy	+1,006	New	+$80.1K	0.01%	1066
2019 Q2	–	Sell	-540	Closed	-$35K	–	1911
2019 Q1	$35K	Buy	+540	New	+$30.1K	﹤0.01%	1249
2018 Q4	–	Sell	-955	Closed	-$49K	–	2023
2018 Q3	$49K	Buy	+955	New	+$39.3K	﹤0.01%	1305

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Virtu Financial's VNRX Position: Q1 2026 in Review

Virtu Financial sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 5,429 shares — an estimated $28K sold.

Virtu Financial first reported a position in VNRX in Q3 2018 and held it in 9 quarters. The position peaked at $173K in Q4 2020. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

Virtu Financial reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 5,429 VolitionRx Ltd shares in Q1 2026, an estimated $28K.
Virtu Financial first reported a position in VolitionRx Ltd in Q3 2018 and held it in 9 quarters.
Virtu Financial's VolitionRx Ltd position peaked at $173K in Q4 2020.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.